{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T11:42:13Z","timestamp":1698579733666},"reference-count":0,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2003,10,31]],"date-time":"2003-10-31T00:00:00Z","timestamp":1067558400000},"content-version":"vor","delay-in-days":2800,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Internal Medicine"],"published-print":{"date-parts":[[1996,3]]},"abstract":"<jats:p> <jats:bold>Objectives. <\/jats:bold>To test whether cardiological syndrome X is an insulin\u2010resistant state.<\/jats:p><jats:p> <jats:bold>Setting, design and subjects. <\/jats:bold>The coronary care unit of a referral centre for angina pectoris in Pisa, Italy. A case\u2010control study, involving 10 patients with unequivocal (angiographycally proven) cardiological syndrome X, but normal glucose tolerance, blood pressure and lipid levels, and 13 matched healthy subjects.<\/jats:p><jats:p> <jats:bold>Main outcome measures. <\/jats:bold>Insulin sensitivity and pattern of substrate oxidation (assessed by the euglycaemic insulin clamp technique in combination with indirect calorimetry).<\/jats:p><jats:p> <jats:bold>Results. <\/jats:bold>Fasting plasma glucose and insulin levels were 5.05\u00b10.11 versus 4.88\u00b10.11 mmol l<jats:sup>\u20101<\/jats:sup> and 68\u00b110 versus 56\u00b16 pmol l<jats:sup>\u20101<\/jats:sup>, respectively (controls versus patients, ns). During the insulin clamp, glucose disposal rate was nearly identical in patients and controls (25.9\u00b11.8 and 27.2\u00b11.8 \u03bcmol kg<jats:sup>\u20101<\/jats:sup> min<jats:sup>\u20101<\/jats:sup>, respectively, <jats:italic>P<\/jats:italic>=0.88). Non\u2010oxidative glucose disposal accounted for similar proportions of total glucose uptake (59 versus 53%, patients versus controls, ns). Resting energy expenditure (13.7\u00b10.6 versus 13.8\u00b10.8 cal kg<jats:sup>\u20101<\/jats:sup> min<jats:sup>\u20101<\/jats:sup>, ns) and insulin\u2010induced thermogenesis were similar in the two groups. Fasting plasma NEFA concentrations (0.64\u00b10.09 and 0.64\u00b10.06 mmol l<jats:sup>\u20101<\/jats:sup>, patients and controls, ns) fell in a similar time\u2010course and to virtually identical nadirs (0.13\u00b10.02 and 0.14\u00b10.02 mmol l<jats:sup>\u20101<\/jats:sup>) after insulin infusion. Fasting plasma potassium was similar in patients and controls (3.99\u00b10.10 and 4.16\u00b10.04 mmol l<jats:sup>\u20101<\/jats:sup>, ns), and insulin induced equivalent hypokalaemia (\u201014 versus \u201019%).<\/jats:p><jats:p> <jats:bold>Conclusions. <\/jats:bold>None of the <jats:italic>in vivo <\/jats:italic>actions of insulin were impaired in patients with when compared to matched controls. Therefore, we conclude that cardiological syndrome X is not an insulin resistant state <jats:italic>per se, <\/jats:italic>and that any decrease in insulin sensitivity found in this condition is likely to be secondary.<\/jats:p>","DOI":"10.1046\/j.1365-2796.1996.448802000.x","type":"journal-article","created":{"date-parts":[[2003,11,2]],"date-time":"2003-11-02T16:26:18Z","timestamp":1067790378000},"page":"241-247","source":"Crossref","is-referenced-by-count":1,"title":["Insulin sensitivity in cardiological syndrome X"],"prefix":"10.1111","volume":"239","author":[{"given":"A.","family":"QUI\u00d1ONES\u2002GALVAN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"NATALI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"MUSCELLI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"CIOCIARO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"PECORI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. G.","family":"CAMICI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"FERRANNINI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,10,31]]},"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2796.1996.448802000.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2796.1996.448802000.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T15:42:21Z","timestamp":1698421341000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2796.1996.448802000.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,3]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1996,3]]}},"alternative-id":["10.1046\/j.1365-2796.1996.448802000.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2796.1996.448802000.x","archive":["Portico"],"relation":{},"ISSN":["0954-6820","1365-2796"],"issn-type":[{"value":"0954-6820","type":"print"},{"value":"1365-2796","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,3]]}}}